Similar articles

• The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

  Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. Carson PE, et al. JACC Heart Fail. 2015 Jun;3(6):429-441. doi: 10.1016/j.jchf.2014.12.017. Epub 2015 May 14. JACC Heart Fail. 2015. PMID: 25982110
• Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.

  Alla F, Al-Hindi AY, Lee CR, Schwartz TA, Patterson JH, Adams KF Jr. Alla F, et al. Am Heart J. 2007 Jun;153(6):1074-80. doi: 10.1016/j.ahj.2007.03.016. Am Heart J. 2007. PMID: 17540212 Clinical Trial.
• Hospitalizations and Prognosis in Elderly Patients With Heart Failure and Preserved Ejection Fraction: Time to Treat the Whole Patient.

  Kitzman DW, Upadhya B, Reeves G. Kitzman DW, et al. JACC Heart Fail. 2015 Jun;3(6):442-444. doi: 10.1016/j.jchf.2015.01.009. Epub 2015 May 14. JACC Heart Fail. 2015. PMID: 25982112 Free PMC article. No abstract available.
• Are beta-blockers effective in heart failure with preserved ejection fraction?

  Alegría J, Rada G. Alegría J, et al. Medwave. 2016 Nov 2;16(Suppl5):e6593. doi: 10.5867/medwave.2016.6593. Medwave. 2016. PMID: 27813500 Review. English, Spanish.
• Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.

  Hoong CW, Lim CP, Gao F, Chen Q, Kawa LB, Ching CK, Sim DK. Hoong CW, et al. J Cardiovasc Med (Hagerstown). 2015 Sep;16(9):583-90. doi: 10.2459/JCM.0000000000000100. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022929 Review.